In situ identification of dimethyl diselenide in hepatocytes treated with methylseleninic acid by membrane inlet mass spectrometry

Charlotte Gabel-Jensen, Søren A. Bak, Frants R. Lauritsen, Helle Rusz Hansen, Lassina Badolo, Bente Gammelgaard (Corresponding Author)

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The advantages and drawbacks of membrane inlet mass spectrometry (MIMS) for identification of volatile selenium compounds were investigated. Hepatocytes were incubated with methylseleninic acid (MeSeA) directly in the MIMS reaction cell and dimethyl diselenide (DMeDSe) was identified as the major volatile metabolite. This compound was also identified as the major reaction product after incubation of glutathione (GSH) with MeSeA without the presence of hepatocytes. One advantage of MIMS is the possibility of in situ monitoring of volatile metabolites with minimum risk of sample loss and without the need for trapping devices. Another advantage is the possibility of concurrent monitoring of cell viability by simultaneous detection of oxygen consumption and CO2 production. Although ideal for screening, the technique suffers from a relative high detection limit (in the 1 mu M range) and lack of robustness. This paper presents for the first time in situ MS data on the formation of DMeDSe.

Original languageEnglish
Pages (from-to)949-952
Number of pages4
JournalJournal of Analytical Atomic Spectrometry
Volume24
Issue number7
Early online date20 May 2009
DOIs
Publication statusPublished - 1 Jul 2009

Keywords

  • GC-ICP-MS
  • cancer prevention
  • selenium
  • incubation
  • vivo

Cite this

In situ identification of dimethyl diselenide in hepatocytes treated with methylseleninic acid by membrane inlet mass spectrometry. / Gabel-Jensen, Charlotte; Bak, Søren A.; Lauritsen, Frants R.; Hansen, Helle Rusz; Badolo, Lassina; Gammelgaard, Bente (Corresponding Author).

In: Journal of Analytical Atomic Spectrometry, Vol. 24, No. 7, 01.07.2009, p. 949-952.

Research output: Contribution to journalArticle

Gabel-Jensen, Charlotte ; Bak, Søren A. ; Lauritsen, Frants R. ; Hansen, Helle Rusz ; Badolo, Lassina ; Gammelgaard, Bente. / In situ identification of dimethyl diselenide in hepatocytes treated with methylseleninic acid by membrane inlet mass spectrometry. In: Journal of Analytical Atomic Spectrometry. 2009 ; Vol. 24, No. 7. pp. 949-952.
@article{23d7611430d04ac8a9d54879b736071a,
title = "In situ identification of dimethyl diselenide in hepatocytes treated with methylseleninic acid by membrane inlet mass spectrometry",
abstract = "The advantages and drawbacks of membrane inlet mass spectrometry (MIMS) for identification of volatile selenium compounds were investigated. Hepatocytes were incubated with methylseleninic acid (MeSeA) directly in the MIMS reaction cell and dimethyl diselenide (DMeDSe) was identified as the major volatile metabolite. This compound was also identified as the major reaction product after incubation of glutathione (GSH) with MeSeA without the presence of hepatocytes. One advantage of MIMS is the possibility of in situ monitoring of volatile metabolites with minimum risk of sample loss and without the need for trapping devices. Another advantage is the possibility of concurrent monitoring of cell viability by simultaneous detection of oxygen consumption and CO2 production. Although ideal for screening, the technique suffers from a relative high detection limit (in the 1 mu M range) and lack of robustness. This paper presents for the first time in situ MS data on the formation of DMeDSe.",
keywords = "GC-ICP-MS, cancer prevention, selenium, incubation, vivo",
author = "Charlotte Gabel-Jensen and Bak, {S{\o}ren A.} and Lauritsen, {Frants R.} and Hansen, {Helle Rusz} and Lassina Badolo and Bente Gammelgaard",
year = "2009",
month = "7",
day = "1",
doi = "10.1039/b903994e",
language = "English",
volume = "24",
pages = "949--952",
journal = "Journal of Analytical Atomic Spectrometry",
issn = "0267-9477",
publisher = "The Royal Society of Chemistry",
number = "7",

}

TY - JOUR

T1 - In situ identification of dimethyl diselenide in hepatocytes treated with methylseleninic acid by membrane inlet mass spectrometry

AU - Gabel-Jensen, Charlotte

AU - Bak, Søren A.

AU - Lauritsen, Frants R.

AU - Hansen, Helle Rusz

AU - Badolo, Lassina

AU - Gammelgaard, Bente

PY - 2009/7/1

Y1 - 2009/7/1

N2 - The advantages and drawbacks of membrane inlet mass spectrometry (MIMS) for identification of volatile selenium compounds were investigated. Hepatocytes were incubated with methylseleninic acid (MeSeA) directly in the MIMS reaction cell and dimethyl diselenide (DMeDSe) was identified as the major volatile metabolite. This compound was also identified as the major reaction product after incubation of glutathione (GSH) with MeSeA without the presence of hepatocytes. One advantage of MIMS is the possibility of in situ monitoring of volatile metabolites with minimum risk of sample loss and without the need for trapping devices. Another advantage is the possibility of concurrent monitoring of cell viability by simultaneous detection of oxygen consumption and CO2 production. Although ideal for screening, the technique suffers from a relative high detection limit (in the 1 mu M range) and lack of robustness. This paper presents for the first time in situ MS data on the formation of DMeDSe.

AB - The advantages and drawbacks of membrane inlet mass spectrometry (MIMS) for identification of volatile selenium compounds were investigated. Hepatocytes were incubated with methylseleninic acid (MeSeA) directly in the MIMS reaction cell and dimethyl diselenide (DMeDSe) was identified as the major volatile metabolite. This compound was also identified as the major reaction product after incubation of glutathione (GSH) with MeSeA without the presence of hepatocytes. One advantage of MIMS is the possibility of in situ monitoring of volatile metabolites with minimum risk of sample loss and without the need for trapping devices. Another advantage is the possibility of concurrent monitoring of cell viability by simultaneous detection of oxygen consumption and CO2 production. Although ideal for screening, the technique suffers from a relative high detection limit (in the 1 mu M range) and lack of robustness. This paper presents for the first time in situ MS data on the formation of DMeDSe.

KW - GC-ICP-MS

KW - cancer prevention

KW - selenium

KW - incubation

KW - vivo

U2 - 10.1039/b903994e

DO - 10.1039/b903994e

M3 - Article

VL - 24

SP - 949

EP - 952

JO - Journal of Analytical Atomic Spectrometry

JF - Journal of Analytical Atomic Spectrometry

SN - 0267-9477

IS - 7

ER -